STOCK TITAN

Tenax Therapeutics: Vestal Point reports 0% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Tenax Therapeutics, Inc. (TENX) is the issuer named in an amended ownership report in which Vestal Point Capital, LP and Ryan Wilder, the investment manager’s Chief Investment Officer and Managing Partner, each report beneficial ownership of 0 shares of common stock, or 0% of the class, as of September 30, 2026. Both also report zero sole and shared voting and dispositive power.

Beneficial ownership 0 shares Each of Vestal Point Capital, LP and Ryan Wilder; event date September 30, 2026
Percent of class 0% Each of Vestal Point Capital, LP and Ryan Wilder
beneficial owner regulatory
"beneficial owner of the securities reported herein"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
dispositive power regulatory
"Sole and shared dispositive power"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TENX shares do Vestal Point Capital and Ryan Wilder report owning?

Each reports beneficial ownership of 0 shares of Tenax Therapeutics common stock, or 0% of the class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





88032L605

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Vestal Point Capital, LP
Signature:/s/ Ryan Wilder
Name/Title:By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Date:11/16/2026
Ryan Wilder
Signature:/s/ Ryan Wilder
Name/Title:Ryan Wilder, Individually
Date:11/16/2026

Keep reading